Go to
JCI Insight
Citations to this article
Miranda K. Culley, Stephen Y. Chan
Published August 6, 2018
Citation Information: J Clin Invest. 2018;128(9):3704-3715. https://doi.org/10.1172/JCI120847.
Citation Information: J Clin Invest. 2018;128(9):3704-3715. https://doi.org/10.1172/JCI120847.
Abstract
Pulmonary hypertension (PH) is a heterogeneous and fatal disease of the lung vasculature, where metabolic and mitochondrial dysfunction may drive pathogenesis. Similar to the Warburg effect in cancer, a shift from mitochondrial oxidation to glycolysis occurs in diseased pulmonary vessels and the right ventricle. However, appreciation of metabolic events in PH beyond the Warburg effect is only just emerging. This Review discusses molecular, translational, and clinical concepts centered on the mitochondria and highlights promising, controversial, and challenging areas of investigation. If we can move beyond the “mountains” of obstacles in this field and elucidate these fundamental tenets of pulmonary vascular metabolism, such work has the potential to usher in much-needed diagnostic and therapeutic approaches for the mitochondrial and metabolic management of PH.
Authors
Miranda K. Culley, Stephen Y. Chan
Total citations by year
Citation information
Citations to this article (100)
| Title and authors | Publication | Year |
|---|---|---|
|
Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2
Sun X, Yegambaram M, Lu Q, Garcia Flores AE, Pokharel MD, Soto J, Aggarwal S, Wang T, Fineman JR, Black SM |
Redox Biology | 2025 |
|
Circulating PGC-1α and MOTS-c Peptide as Potential Mitochondrial Biomarkers in Patients Undergoing Aortic Valve Replacement
Sánchez-Quintero MJ, Iboleón A, Martín Chaves L, Pozo Vilumbrales B, Carmona-Segovia AD, Martínez López P, Romero-Cuevas M, Rodríguez-Capitán J, Becerra-Muñoz VM, Pavón-Morón FJ, Murri M |
Biologics : Targets & Therapy | 2025 |
|
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs
Wang Y, Wang Y, Zhang W |
Reviews in Cardiovascular Medicine | 2025 |
|
Pulmonary hypertension and insulin resistance: a mechanistic overview
Zanotto TM, Gonçalves AE, Saad MJ |
Frontiers in Endocrinology | 2024 |
|
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension
Tai YY, Yu Q, Tang Y, Sun W, Kelly NJ, Okawa S, Zhao J, Schwantes-An TH, Lacoux C, Torrino S, Aaraj YA, Khoury WE, Negi V, Liu M, Corey CG, Belmonte F, Vargas SO, Schwartz B, Bhat B, Chau BN, Karnes JH, Satoh T, Barndt RJ, Wu H, Parikh VN, Wang J, Zhang Y, McNamara D, Li G, Speyer G, Wang B, Shiva S, Kaufman B, Kim S, Gomez D, Mari B, Cho MH, Boueiz A, Pauciulo MW, Southgate L, Trembath RC, Sitbon O, Humbert M, Graf S, Morrell NW, Rhodes CJ, Wilkins MR, Nouraie M, Nichols WC, Desai AA, Bertero T, Chan SY |
Science Translational Medicine | 2024 |
|
FAK mediates hypoxia‐induced pulmonary artery smooth muscle cell proliferation by modulating mitochondrial transcription termination factor 1/cyclin D1
Lin C, Yang H, Luo Q, Liu Q |
Clinical and Translational Science | 2024 |
|
Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
Rao RJ, Chan SY |
Circulation | 2024 |
|
Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside
Correale M, Chirivì F, Bevere EM, Tricarico L, D\u2019Alto M, Badagliacca R, Brunetti ND, Vizza CD, Ghio S |
Journal of Clinical Medicine | 2024 |
|
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
Riou M, Coste F, Meyer A, Enache I, Talha S, Charloux A, Reboul C, Geny B |
International journal of molecular sciences | 2024 |
|
STAT3 phosphorylation at Tyr705 affects DRP1 (dynamin-related protein 1) controlled-mitochondrial fission during the development of apoptotic-resistance in pulmonary arterial endothelial cells.
Zhang H, Chen L, Li J, Sun J, Zhao Q, Wang S, Li G |
Genes & Genomics | 2024 |
|
Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms
Zhang H, Li M, Hu CJ, Stenmark KR |
Cells | 2024 |
|
β-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats.
Meng H, Deng Y, Liao J, Wu DD, Li LX, Chen X, Lan WF |
BMC Cardiovascular Disorders | 2024 |
|
Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain
Safaie Qamsari E, Stewart DJ |
Frontiers in Immunology | 2024 |
|
Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension.
Santos RT, de Sá Freire Onofre ME, de Assis Fernandes Caldeira D, Klein AB, Rocco PRM, Cruz FF, Silva PL |
Current vascular pharmacology | 2024 |
|
Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis.
Zhang J, Yan H, Wang Y, Yue X, Wang M, Liu L, Qiao P, Zhu Y, Li Z |
Molecular and cellular biochemistry | 2024 |
|
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight
Namazi M, Eftekhar SP, Mosaed R, Shiralizadeh Dini S, Hazrati E |
Clinical Medicine Insights. Cardiology | 2024 |
|
Oroxylin A, a broad‑spectrum anticancer agent, relieves monocrotaline‑induced pulmonary arterial hypertension by inhibiting the Warburg effect in rats.
Wang Y, Fan Y, Zhou Y, Chen T, Xu S, Liu J, Li L |
Molecular medicine reports | 2024 |
|
Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension
Niihori M, James J, Varghese MV, McClain N, Lawal OS, Philip RC, Baggett BK, Goncharov DA, de Jesus Perez V, Goncharova EA, Rafikov R, Rafikova O |
The Journal of Experimental Medicine | 2024 |
|
Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism
Krause PN, McGeorge G, McPeek JL, Khalid S, Nelin LD, Liu Y, Chen B |
Physiological Reports | 2024 |
|
Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach.
Mitra A, Yi D, Dai Z, de Jesus Perez V |
Frontiers in medicine | 2024 |
|
Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review).
Chen M, Li H, Li Y, Luo Y, He Y, Shui X, Lei W |
International journal of molecular medicine | 2024 |
|
Honokiol and Nicotinamide Adenine Dinucleotide Improve Exercise Endurance in Pulmonary Hypertensive Rats Through Increasing SIRT3 Function in Skeletal Muscle
Li M, McKeon BA, Gu S, Prasad RR, Zhang H, Kumar S, Riddle S, Irwin DC, Stenmark KR |
International Journal of Molecular Sciences | 2024 |
|
Ferroptosis Mediated Inflammation Promotes Pulmonary Hypertension
Kazmirczak F, Vogel NT, Prisco SZ, Patterson MT, Annis J, Moon RT, Hartweck LM, Mendelson JB, Kim M, Mancipe NC, Markowski T, Higgins L, Guerrero C, Kremer B, Blake ML, Rhodes CJ, Williams JW, Brittain EL, Prins KW |
Circulation research | 2024 |
|
PI3K p85α/HIF-1α accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagy
Chen C, Qin S, Song X, Wen J, Huang W, Sheng Z, Li X, Cao Y |
Molecular Medicine | 2024 |
|
Lipocalin‐2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension
Wang G, Liu S, Kong X, Jiao H, Tong F, Guo Z, Zhang M, Guan X, Ren N, Li W, Qi L, Wei Y |
Cell Proliferation | 2024 |
|
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes
You Q, Song H, Zhu Z, Wang J, Wang R, Du M, Fu Y, Yuan J, Tan R |
Cellular & Molecular Biology Letters | 2024 |
|
Ginsenoside Rg1 improves hypoxia-induced pulmonary vascular endothelial dysfunction through TXNIP/NLRP3 pathway-modulated mitophagy
Zhang R, Lu M, Ran C, Niu L, Qi Q, Wang H |
Journal of Ginseng Research | 2024 |
|
Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development
Ahmed AS, Blood AB, Zhang L |
Drug discovery today | 2024 |
|
MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux
Ahmed AS, Blood AB, Zhang L |
Acta physiologica (Oxford, England) | 2024 |
|
The mitochondrial redistribution of ENOS is regulated by AKT1 and dimer status.
Sun X, Moreno Caceres S, Yegambaram M, Lu Q, Pokharel MD, Boehme JT, Datar SA, Aggarwal S, Wang T, Fineman JR, Black SM |
Nitric oxide : biology and chemistry | 2024 |
|
Novel variants of seryl-tRNA synthetase resulting in HUPRA syndrome featured in pulmonary hypertension
Yang F, Wang D, Zhang X, Fan H, Zheng Y, Xiao Z, Chen Z, Xiao Y, Liu Q |
Frontiers in Cardiovascular Medicine | 2023 |
|
Ferroptosis Promotes Pulmonary Hypertension
Vogel NT, Annis J, Prisco SZ, Kazmirczak F, Brittain EL, Prins KW |
2023 | |
|
Mitochondrial Dysfunction in Pulmonary Hypertension
Ryanto GR, Suraya R, Nagano T |
Antioxidants | 2023 |
|
Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial
Verdejo HE, Rojas A, López-Crisosto C, Baraona F, Gabrielli L, Maracaja-Coutinho V, Chiong M, Lavandero S, Castro PF |
Journal of Clinical Medicine | 2023 |
|
JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension
Zhang C, Sun Y, Guo Y, Xu J, Zhao H |
Cell Death Discovery | 2023 |
|
SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics
Sangam S, Sun X, Schwantes-An TH, Yegambaram M, Lu Q, Shi Y, Cook T, Fisher A, Frump AL, Coleman A, Sun Y, Liang S, Crawford H, Lutz KA, Maun AD, Pauciulo MW, Karnes JH, Chaudhary KR, Stewart DJ, Langlais PR, Jain M, Alotaibi M, Lahm T, Jin Y, Gu H, Tang H, Nichols WC, Black SM, Desai AA |
American journal of respiratory and critical care medicine | 2023 |
|
Crucial role of iron in epigenetic rewriting during adipocyte differentiation mediated by JMJD1A and TET2 activity
Suzuki T, Komatsu T, Shibata H, Tanioka A, Vargas D, Kawabata-Iwakawa R, Miura F, Masuda S, Hayashi M, Tanimura-Inagaki K, Morita S, Kohmaru J, Adachi K, Tobo M, Obinata H, Hirayama T, Kimura H, Sakai J, Nagasawa H, Itabashi H, Hatada I, Ito T, Inagaki T |
Nucleic Acids Research | 2023 |
|
Cardiometabolic Risk Factors Associated With Right Ventricular Function and Compensation in Patients Referred for Echocardiography
Morrison AM, Huang S, Annis JS, Garry JD, Hemnes AR, Freiberg MS, Brittain EL |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2023 |
|
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
Pokharel MD, Marciano DP, Fu P, Franco MC, Unwalla H, Tieu K, Fineman JR, Wang T, Black SM |
Redox Biology | 2023 |
|
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function
Culley MK, Rao RJ, Mehta M, Zhao J, Khoury WE, Harvey LD, Perk D, Tai YY, Tang Y, Shiva S, Rabinovitch M, Gu M, Bertero T, Chan SY |
Vascular Pharmacology | 2023 |
|
Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension
Hopkins CD, Wessel C, Chen O, El-Kersh K, Cave MC, Cai L, Huang J |
International journal of biological sciences | 2023 |
|
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension
Li M, Plecitá-Hlavatá L, Dobrinskikh E, McKeon BA, Gandjeva A, Riddle S, Laux A, Prasad RR, Kumar S, Tuder RM, Zhang H, Hu CJ, Stenmark KR |
American journal of respiratory cell and molecular biology | 2023 |
|
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
Singh N, Eickhoff C, Garcia-Agundez A, Bertone P, Paudel SS, Tambe DT, Litzky LA, Cox-Flaherty K, Klinger JR, Monaghan SF, Mullin CJ, Pereira M, Walsh T, Whittenhall M, Stevens T, Harrington EO, Ventetuolo CE |
Scientific Reports | 2023 |
|
Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells
Yegambaram M, Sun X, Flores AG, Lu Q, Soto J, Richards J, Aggarwal S, Wang T, Gu H, Fineman JR, Black SM |
International journal of molecular sciences | 2023 |
|
Mitochondria-derived Vesicle Packaging as a Novel Therapeutic Mechanism in Pulmonary Hypertension
Zhao Q, Liu Z, Song P, Yuan Z, Zou MH |
American journal of respiratory cell and molecular biology | 2023 |
|
Mitochondrial Hyperfusion Induces Metabolic Remodeling In Lung Endothelial Cells By Modifying The Activities Of Electron Transport Chain Complexes I And III
Yegambaram M, Sun X, Lu Q, Jin Y, Ornatowski W, Soto J, Aggarwal S, Wang T, Tieu K, Gu H, Fineman JR, Black SM |
Free radical biology & medicine | 2023 |
|
Endothelial Senescence: A New Age in Pulmonary Hypertension
M Culley, S Chan |
Circulation research | 2022 |
|
Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension
S Liang, M Yegambaram, T Wang, J Wang, S Black, H Tang |
Biomedicines | 2022 |
|
Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism
Q Wang, Y Sun, Q Zhao, W Wu, L Wang, Y Miao, P Yuan |
2022 | |
|
Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension
D Hidalgo, H Elajaili, H Suliman, M George, C Delaney, E Nozik |
Antioxidants | 2022 |
|
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
L Calvier, J Herz, G Hansmann |
JACC: Basic to Translational Science | 2022 |
|
Association of asymmetric dimethylarginine with the pathological process of persistent pulmonary hypertension of the newborn
Wen-Ting Zhang, Qin Lu, Jie-Jun Ding, Meng Gu |
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics | 2022 |
|
The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells
C Huang, Z Jiang, D Du, Z Zhang, Y Liu, Y Li |
Laboratory Investigation | 2022 |
|
Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups
C DAddario, G Lanier, C Jacob, N Bauer, J Hewes, A Bhadra, S Gupte |
Physiological Reports | 2022 |
|
Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery
Azhdari MH, Goodarzi N, Doroudian M, MacLoughlin R |
International journal of molecular sciences | 2022 |
|
Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension
Jiang L, Goncharov DA, Shen Y, Lin D, Chang B, Pena A, DeLisser H, Goncharova EA, Kudryashova TV |
Frontiers in Medicine | 2022 |
|
Proteomic and Metabolomic Analyses of Right Ventricular Failure due to Pulmonary Arterial Hypertension
Qin X, Lei C, Yan L, Sun H, Liu X, Guo Z, Sun W, Guo X, Fang Q |
Frontiers in Molecular Biosciences | 2022 |
|
Future Perspectives of Pulmonary Hypertension Treatment
Hsu CH, Huang WC, Chang WT |
2022 | |
|
Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension
Sommer N, Theine FF, Pak O, Tello K, Richter M, Gall H, Wilhelm J, Savai R, Weissmann N, Seeger W, Ghofrani HA, Hecker M |
Journal of Clinical Medicine | 2022 |
|
The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis
Xu W, Deng M, Meng X, Sun X, Tao X, Wang D, Zhang S, Zhen Y, Liu X, Liu M |
Frontiers in Cardiovascular Medicine | 2022 |
|
Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension
Wang J, Uddin MN, Wang R, Gong YH, Wu Y |
Frontiers in Genetics | 2022 |
|
Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure
Banerjee S, Hong J, Umar S |
Frontiers in Cardiovascular Medicine | 2022 |
|
PGC-1α activity and mitochondrial dysfunction in preterm infants
Mohammadi A, Higazy R, Gauda EB |
Frontiers in physiology | 2022 |
|
3’UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension
Tseng V, Collum SD, Allawzi A, Crotty K, Yeligar S, Trammell A, Smith MR, Kang BY, Sutliff RL, Ingram JL, Jyothula SS, Thandavarayan RA, Huang HJ, Nozik ES, Wagner EJ, Hart CM, Karmouty-Quintana H |
Matrix biology : journal of the International Society for Matrix Biology | 2022 |
|
Mediterranean G6PD variant mitigates expression of DNA methyltransferases and right heart pressure in experimental model of pulmonary hypertension
Jacob C, Kitagawa A, Signoretti C, Dzieciatkowska M, D\u2019Alessandro A, Gupte A, Hossain S, D\u2019Addario CA, Gupte R, Gupte SA |
The Journal of biological chemistry | 2022 |
|
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension
Zhang V, Ganz T, Nemeth E, Umar S, Kim A |
Pulmonary circulation | 2022 |
|
Mitochondrial dysfunction in pulmonary arterial hypertension
Zhang W, Liu B, Wang Y, Zhang H, He L, Wang P, Dong M |
Frontiers in physiology | 2022 |
|
Intracellular Chloride Channels Regulate Endothelial Metabolic Reprogramming in Pulmonary Arterial Hypertension
Alzaydi MM, Abdul-Salam VB, Whitwell HJ, Russomanno G, Glynos A, Capece D, Szabadkai G, Wilkins MR, Wojciak-Stothard B |
American journal of respiratory cell and molecular biology | 2022 |
|
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target
S Karnati, M Seimetz, F Kleefeldt, A Sonawane, T Madhusudhan, A Bachhuka, D Kosanovic, N Weissmann, K Krüger, S Ergün |
Frontiers in Cardiovascular Medicine | 2021 |
|
Genetic Delivery and Gene Therapy in Pulmonary Hypertension
N Rai, M Shihan, W Seeger, RT Schermuly, T Novoyatleva |
International journal of molecular sciences | 2021 |
|
Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function
X Lu, J Zhang, H Liu, W Ma, L Yu, X Tan, S Wang, F Ren, X Li, X Li |
Theranostics | 2021 |
|
PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
G Kökény, L Calvier, G Hansmann |
International journal of molecular sciences | 2021 |
|
miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension
G Russomanno, KB Jo, VB Abdul-Salam, C Morgan, J Endruschat, U Schaeper, AH Osman, MM Alzaydi, MR Wilkins, B Wojciak-Stothard |
Molecular Therapy — Nucleic Acids | 2021 |
|
Hydrogen Sulfide Metabolism and Pulmonary Hypertension
L Roubenne, R Marthan, BL Grand, C Guibert |
Cells | 2021 |
|
A Shift from Glycolytic and Fatty Acid Derivatives toward One-Carbon Metabolites in the Developing Lung During Transitions of the Early Postnatal Period
DD Lee, SJ Park, K Zborek, MA Schwarz |
American journal of physiology. Lung cellular and molecular physiology | 2021 |
|
Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways
M Wujak, C Veith, CY Wu, T Wilke, ZI Kanbagli, T Novoyatleva, A Guenther, W Seeger, F Grimminger, N Sommer, RT Schermuly, N Weissmann |
International journal of molecular sciences | 2021 |
|
Gestational long-term hypoxia induces metabolomic reprogramming and phenotypic transformations in fetal sheep pulmonary arteries
E Leslie, V Lopez, NA Anti, R Alvarez, I Kafeero, DG Welsh, M Romero, S Kaushal, CM Johnson, R Bosviel, I Blaženović, R Song, A Brito, MR Frano, L Zhang, JW Newman, O Fiehn, SM Wilson |
American journal of physiology. Lung cellular and molecular physiology | 2021 |
|
Mitofusin-2: A New Mediator of Pathological Cell Proliferation
Y Xin, J Li, W Wu, X Liu |
Frontiers in Cell and Developmental Biology | 2021 |
|
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension
S Dikalov, A Dikalova |
Current Opinion in Nephrology and Hypertension | 2021 |
|
Prognostic significance of insulin resistance in pulmonary hypertension
E Zare, P Kafshbani, M Chenaghlou, M Noori, Z Ghaemmaghami, A Amin, S Taghavi, N Naderi |
ESC Heart Failure | 2021 |
|
Lung Metabolomics Profiling of Congenital Diaphragmatic Hernia in Fetal Rats
M del Mar Romero-Lopez, M Oria, M Watanabe-Chailland, M Varela, L Romick-Rosendale, J Peiro |
Metabolites | 2021 |
|
Blood-based bioenergetics: An emerging translational and clinical tool
A Braganza, GK Annarapu, S Shiva |
Molecular Aspects of Medicine | 2020 |
|
Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
A Hemnes, AM Rothman, AJ Swift, LS Zisman |
Pulmonary circulation | 2020 |
|
NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19
F Potus, V Mai, M Lebret, S Malenfant, E Breton-Gagnon, AC Lajoie, O Boucherat, S Bonnet, S Provencher |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension
EM Swietlik, M Prapa, JM Martin, D Pandya, K Auckland, NW Morrell, S Gräf |
Genes & development | 2020 |
|
Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
Y Xiao, PP Chen, RL Zhou, Y Zhang, Z Tian, SY Zhang |
Aging and disease | 2020 |
|
Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension
G Hansmann, L Calvier, MG Risbano, SY Chan |
American journal of respiratory cell and molecular biology | 2020 |
|
Endoplasmic reticulum stress and pulmonary hypertension
Y Hu, W Yang, L Xie, T Liu, H Liu, B Liu |
Pulmonary circulation | 2020 |
|
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment
D Hernandez-Saavedra, L Sanders, S Freeman, JA Reisz, MH Lee, C Mickael, R Kumar, B Kassa, S Gu, AD Alessandro, KR Stenmark, RM Tuder, BB Graham |
Scientific Reports | 2020 |
|
Clinical and molecular basis of hepatocerebral mitochondrial DNA depletion syndrome in Japan: evaluation of outcomes after liver transplantation
M Shimura, N Kuranobu, M Ogawa-Tominaga, N Akiyama, Y Sugiyama, T Ebihara, T Fushimi, K Ichimoto, A Matsunaga, T Tsuruoka, Y Kishita, S Umetsu, A Inui, T Fujisawa, K Tanikawa, R Ito, A Fukuda, J Murakami, S Kaji, M Kasahara, K Shiraki, A Ohtake, Y Okazaki, K Murayama |
Orphanet Journal of Rare Diseases | 2020 |
|
Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer X Yang, L Wang, L Lin, X Liu |
Cancer management and research | 2020 |
|
NFU1, Iron-Sulfur Biogenesis, and Pulmonary Arterial Hypertension: A (Metabolic) Shift in Our Thinking
MK Culley, D Perk, SY Chan |
American journal of respiratory cell and molecular biology | 2020 |
|
Complex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape
J James, MV Varghese, M Vasilyev, PR Langlais, SP Tofovic, O Rafikova, R Rafikov |
International journal of molecular sciences | 2020 |
|
Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fraction
RJ Bernardo, F Haddad, EJ Couture, G Hansmann, VA de Jesus Perez, AY Denault, FS de Man, M Amsallem |
Cardiovascular diagnosis and therapy | 2020 |
|
The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care
A Sabbahi, R Severin, C Ozemek, S Phillips, R Arena |
Expert Review of Respiratory Medicine | 2020 |
|
Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature
D Wu, K Birukov |
Frontiers in Bioengineering and Biotechnology | 2019 |
|
Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension
HB Suliman, E Nozik-Grayck |
Antioxidants & Redox Signaling | 2019 |
|
Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development
O Rafikova, IA Ghouleh, R Rafikov |
Antioxidants & Redox Signaling | 2019 |
|
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
T Bertero, D Perk, SY Chan |
Expert Opinion on Therapeutic Targets | 2019 |
|
Precision medicine – the future of diagnostic approach to pulmonary hypertension?
P Kedzierski |
Anatolian Journal of Cardiology | 2019 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)